Anti–programmed death ligand 1 immunotherapies in cancer patients with pre-existing systemic sclerosis: A postmarketed phase IV safety assessment study
Titel:
Anti–programmed death ligand 1 immunotherapies in cancer patients with pre-existing systemic sclerosis: A postmarketed phase IV safety assessment study
Auteur:
Panhaleux, Marion Espitia, Olivier Terrier, Benjamin Manson, Guillaume Maria, Alexandre Humbert, Sébastien Godbert, Benoît Perrin, Julie Achille, Aurélie Arrondeau, Jennifer Kostine, Marie Fallet, Vincent Pugnet, Grégory Chaigne, Benjamin Champiat, Stéphane Laparra, Ariane Danlos, Francois-Xavier Launay, David Penel, Nicolas Lambotte, Olivier Michot, Jean-Marie Forestier, Alexandra